The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 24, 2026 | Litchman Manuel MD | President, CEO and Interim CFO, Director | Tax withholding(F) | 19 | $0.75 | $14 |
| Jan 2, 2026 | Fortress Biotech, Inc. | 10% Owner | Grant(A) | 278K | — | $0 |
| Dec 30, 2025 | Jin David | Director | Buy(P) | 247 | $0.96 | $237 |
| Dec 30, 2025 | Chill Adam J. | Director | Sell(S) | 4 | $0.95 | $4 |
| Dec 30, 2025 | Herskowitz Neil | Director | Sell(S) | 247 | $0.96 | $237 |
| Sep 29, 2025 | Fortress Biotech, Inc. | 10% Owner | Grant(A) | 59K | — | $0 |
| Apr 24, 2025 | Litchman Manuel MD | President, CEO and Interim CFO, Director | Tax withholding(F) | 27 | $1.24 | $33 |
| Mar 31, 2025 | Fortress Biotech, Inc. | 10% Owner | Grant(A) | 68K | — | $0 |
| Jun 27, 2024 | Fortress Biotech, Inc. | 10% Owner | Grant(A) | 575K | — | $0 |
| May 31, 2024 | Litchman Manuel MD | President and CEO, Director | Tax withholding(F) | 1K | $0.35 | $489 |
| Jan 2, 2024 | Fortress Biotech, Inc. | 10% Owner | Grant(A) | 419K | — | $0 |
| Jul 5, 2023 | Herskowitz Neil | Director | Grant(A) | 7K | — | $0 |
| Jul 5, 2023 | Weiss Michael S | Director | Grant(A) | 7K | — | $0 |
| Jul 5, 2023 | Rosenwald Lindsay A MD | Director | Grant(A) | 7K | — | $0 |
| Jul 5, 2023 | Chill Adam J. | Director | Grant(A) | 7K | — | $0 |
| Jul 5, 2023 | Zelefsky Michael J | Director | Grant(A) | 7K | — | $0 |
| Apr 24, 2023 | Litchman Manuel MD | President and CEO, Director | Tax withholding(F) | 2K | $4.21 | $7K |
| Apr 24, 2023 | Litchman Manuel MD | President and CEO, Director | Grant(A) | 5K | — | $0 |
| Jan 6, 2023 | Fortress Biotech, Inc. | 10% Owner | Grant(A) | 2.8M | — | $0 |
| Sep 13, 2022 | Rosenwald Lindsay A MD | Director | Buy(P) | 5K | $0.52 | $3K |
| Sep 13, 2022 | Litchman Manuel MD | Director | Buy(P) | 5K | $0.52 | $3K |
| Jul 29, 2022 | Weiss Michael S | Director | Grant(A) | 72K | — | $0 |
| Jul 29, 2022 | Chill Adam J. | Director | Grant(A) | 72K | — | $0 |
| Jul 29, 2022 | Zelefsky Michael J | Director | Grant(A) | 72K | — | $0 |
| Jul 29, 2022 | Herskowitz Neil | Director | Grant(A) | 72K | — | $0 |
| Jul 29, 2022 | Rosenwald Lindsay A MD | Director | Grant(A) | 72K | — | $0 |
| Jun 21, 2022 | Litchman Manuel MD | Director | Grant(A) | 61K | — | $0 |
| Apr 24, 2022 | Litchman Manuel MD | President and CEO, Director | Tax withholding(F) | 1K | $12.15as filed | — |
| Mar 18, 2022 | Rosenwald Lindsay A MD | Director | Buy(P) | 4K | $0.74 | $3K |
| Mar 18, 2022 | Litchman Manuel MD | Director | Buy(P) | 5K | $0.74 | $4K |
| Dec 14, 2021 | Achenbach Brian | SVP, Fin. & Corp. Controller | Sell(S) | 4K | $1.83 | $8K |
| Dec 8, 2021 | Achenbach Brian | SVP, Fin. & Corp. Controller | Grant(A) | 23K | — | $0 |
| Oct 27, 2021 | Litchman Manuel MD | President and CEO, Director | Buy(P) | 65K | $2.24 | $146K |
| Oct 12, 2021 | Achenbach Brian | SVP, Fin. & Corp. Controller | Sell(S) | 4K | $2.28 | $10K |
| Aug 31, 2021 | Litchman Manuel MD | President and CEO, Director | Grant(A) | 3K | $2.58 | $7K |
| Aug 31, 2021 | Rosenwald Lindsay A MD | Director | Grant(A) | 1K | $2.58 | $3K |
| Jul 30, 2021 | Litchman Manuel MD | President and CEO, Director | Buy(P) | 86K | $2.91 | $251K |
| Jun 28, 2021 | Chill Adam J. | Director | Grant(A) | 14K | — | $0 |
| Jun 28, 2021 | Herskowitz Neil | Director | Grant(A) | 14K | — | $0 |
| Jun 28, 2021 | Rosenwald Lindsay A MD | Director | Grant(A) | 14K | — | $0 |
| Jun 28, 2021 | Weiss Michael S | Director | Grant(A) | 14K | — | $0 |
| Jun 28, 2021 | Zelefsky Michael J | Director | Grant(A) | 14K | — | $0 |
| Jun 17, 2021 | Litchman Manuel MD | President and CEO, Director | Grant(A) | 61K | — | $0 |
| Apr 9, 2021 | Achenbach Brian | SVP, Fin. & Corp. Controller | Sell(S) | 2K | $3.36 | $8K |
| Mar 5, 2021 | Litchman Manuel MD | President and CEO, Director | Buy(P) | 166K | $3.12 | $517K |
| Feb 26, 2021 | Rosenwald Lindsay A MD | Director | Grant(A) | 1K | $2.83 | $3K |
| Feb 26, 2021 | Litchman Manuel MD | President and CEO, Director | Grant(A) | 5K | $2.83 | $14K |
| Dec 15, 2020 | Achenbach Brian | SVP, Fin. & Corp. Controller | Grant(A) | 23K | — | $0 |
| Dec 15, 2020 | Litchman Manuel MD | President and CEO, Director | Buy(P) | 100K | $2.91 | $291K |
| Dec 14, 2020 | Rosenwald Lindsay A MD | Director | Buy(P) | 100K | $2.66 | $266K |
| Dec 8, 2020 | Achenbach Brian | SVP, Fin. & Corp. Controller | Sell(S) | 5K | $3.03 | $16K |
| Oct 21, 2020 | Achenbach Brian | SVP, Fin. & Corp. Controller | Sell(S) | 3K | $2.97 | $9K |
| Sep 15, 2020 | Litchman Manuel MD | President and CEO, Director | Grant(A) | 61K | — | $0 |
| Aug 31, 2020 | Litchman Manuel MD | President and CEO, Director | Grant(A) | 5K | $2.48 | $12K |
| Aug 31, 2020 | Rosenwald Lindsay A MD | Director | Grant(A) | 1K | $2.48 | $3K |
| Jul 14, 2020 | Rosenwald Lindsay A MD | Director | Grant(A) | 17K | $2.48 | $41K |
| Jul 14, 2020 | Chill Adam J. | Director | Grant(A) | 17K | — | $0 |
| Jul 14, 2020 | Herskowitz Neil | Director | Grant(A) | 17K | — | $0 |
| Jul 14, 2020 | Weiss Michael S | Director | Grant(A) | 17K | — | $0 |
| Jul 14, 2020 | Zelefsky Michael J | Director | Grant(A) | 17K | — | $0 |
| Jun 11, 2020 | Litchman Manuel MD | President and CEO, Director | Buy(P) | 154K | $3.25 | $500K |
| May 22, 2020 | Achenbach Brian | SVP, Fin. & Corp. Controller | Sell(S) | 880 | $3.04 | $3K |
| May 22, 2020 | Litchman Manuel MD | President and CEO, Director | Sell(S) | 8K | $3.04 | $25K |
| May 22, 2020 | Litchman Manuel MD | President and CEO, Director | Sell(S) | 4K | $3.04 | $12K |
| May 21, 2020 | Litchman Manuel MD | President and CEO, Director | Buy(P) | 90K | $3.13 | $282K |
| May 14, 2020 | Litchman Manuel MD | President and CEO, Director | Buy(P) | 90K | $2.79 | $251K |
| Mar 31, 2020 | Achenbach Brian | SVP, Fin. & Corp. Controller | Sell(S) | 3K | $2.64 | $8K |
| Mar 26, 2020 | Achenbach Brian | SVP, Fin. & Corp. Controller | Grant(A) | 36K | — | $0 |
| Mar 26, 2020 | Litchman Manuel MD | President and CEO, Director | Grant(A) | 122K | — | $0 |
| Mar 5, 2020 | Achenbach Brian | SVP, Fin. & Corp. Controller | Grant(A) | 524 | $2.48 | $1K |
| Mar 5, 2020 | Litchman Manuel MD | President and CEO, Director | Grant(A) | 5K | $2.48 | $12K |
| Feb 28, 2020 | Rosenwald Lindsay A MD | Director | Grant(A) | 831 | $2.48 | $2K |
| Dec 6, 2019 | Achenbach Brian | SVP, Fin. & Corp. Controller | Sell(S) | 6K | $3.69 | $23K |
| Aug 28, 2019 | Rosenwald Lindsay A MD | Director | Grant(A) | 14K | — | $0 |
| Aug 28, 2019 | Weiss Michael S | Director | Grant(A) | 14K | — | $0 |
| Aug 28, 2019 | Chill Adam J. | Director | Grant(A) | 14K | — | $0 |
| Aug 28, 2019 | Herskowitz Neil | Director | Grant(A) | 14K | — | $0 |
| Apr 16, 2019 | Achenbach Brian | SVP, Fin. & Corp. Controller | Grant(A) | 35K | — | $0 |
| Dec 10, 2018 | Litchman Manuel MD | President and CEO, Director | Buy(P) | 8K | $3.35 | $27K |
| Dec 4, 2018 | Litchman Manuel MD | President and CEO, Director | Buy(P) | 8K | $3.60 | $27K |
| Nov 26, 2018 | Litchman Manuel MD | President and CEO, Director | Buy(P) | 5K | $3.87 | $19K |
| Nov 23, 2018 | Herskowitz Neil | Director | Buy(P) | 1K | $3.96 | $4K |
| Nov 21, 2018 | Litchman Manuel MD | President and CEO, Director | Buy(P) | 5K | $4.21 | $21K |
| Nov 20, 2018 | Achenbach Brian | VP, Fin. & Corp. Controller | Buy(P) | 500 | $3.87 | $2K |
| Nov 20, 2018 | Litchman Manuel MD | President and CEO, Director | Buy(P) | 3K | $3.89 | $10K |
| Nov 19, 2018 | Achenbach Brian | VP, Fin. & Corp. Controller | Buy(P) | 1K | $4.25 | $4K |
| Nov 16, 2018 | Achenbach Brian | VP, Fin. & Corp. Controller | Buy(P) | 1K | $4.31 | $4K |
| Nov 12, 2018 | Chill Adam J. | Director | Grant(A) | 1K | $4.85 | $5K |
| Nov 8, 2018 | Chill Adam J. | Director | Grant(A) | 2K | $5.34 | $11K |
| Jun 14, 2018 | Rosenwald Lindsay A MD | Director | Grant(A) | 10K | — | $0 |
| Jun 14, 2018 | Weiss Michael S | Director | Grant(A) | 10K | — | $0 |
| Jun 14, 2018 | Chill Adam J. | Director | Grant(A) | 10K | — | $0 |
| Jun 14, 2018 | Herskowitz Neil | Director | Grant(A) | 10K | — | $0 |
| Feb 2, 2018 | Achenbach Brian | VP, Fin. & Corp. Controller | Grant(A) | 55K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Mustang Bio, Inc., SEC CIK 0001680048. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under MBIO and shows every filing by that issuer.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-15. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for MBIO